Clinical Trials

NCT07087860 | RECRUITING | PHASE2
70 participants

Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-08
Start Date:
2025-08-01
Completion:
2028-08-07
Conditions
  • Metastatic Bladder Urothelial Carcinoma
  • Metastatic Renal Pelvis and Ureter Urothelial Carcinoma
  • Refractory Bladder Urothelial Carcinoma
  • Refractory Renal Pelvis and Ureter Urothelial Carcinoma
  • Stage IV Bladder Cancer AJCC v7
  • Stage IV Renal Pelvis and Ureter Cancer AJCC v7
Interventions
  • OTHER
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT07086222 | ACTIVE_NOT_RECRUITING | PHASE4
6500 participants

Efficacy and Safety of NVX-CoV2705

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-08
Start Date:
2025-11-20
Completion:
2026-11-18
Conditions
  • COVID-19
  • Sars-CoV-2 Infection
Interventions
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page